Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,320 papers from all fields of science
Search
Sign In
Create Free Account
Circulating Tumor Cell Count
Known as:
CTC
, Circulating Tumor Cells
The determination of the amount of circulating tumor cells present in a sample.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
CDISC SDTM Laboratory Test Terminology by Code
CDISC SDTM Laboratory Test Terminology by Name
Circulating Neoplastic Cells
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Efficacy, safety and tolerability of MEDI4736 (durvalumab [D]), a human IgG1 anti‐programmed cell death‐ligand‐1 (PD‐L1) antibody, combined with gefitinib (G): A phase I expansion in TKI‐naïve…
D. Gibbons
,
Laura Qm Chow
,
+7 authors
B. Creelan
Journal of Thoracic Oncology
2016
Corpus ID: 36414628
2016
2016
Precision Microfilters as an all in one System for Multiplex Analysis of Circulating Tumor Cells.
D. Adams
,
R. Alpaugh
,
+10 authors
S. Stefansson
RSC Advances
2016
Corpus ID: 40550721
Enumeration of circulating tumor cells (CTCs) from cancer patient blood is an established diagnostic assay used to evaluate…
Expand
2015
2015
Combining Mitomycin C and Regional 70 MHz Hyperthermia in Patients with Nonmuscle Invasive Bladder Cancer: A Pilot Study.
E. D. Geijsen
,
T. D. de Reijke
,
+5 authors
J. Crezee
Journal of Urology
2015
Corpus ID: 37161569
2013
2013
Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff?
P. Gazzaniga
,
C. Raimondi
,
+12 authors
E. Cortesi
Journal of Cancer Research and Clinical Oncology
2013
Corpus ID: 24523494
PurposeTo assess the prognostic and predictive value of circulating tumor cells (CTCs) in metastatic colorectal cancer (mCRC…
Expand
Review
2012
Review
2012
Role of circulating tumor cells and disseminated tumor cells in primary breast cancer
N. Hayashi
,
H. Yamauchi
Breast Cancer
2012
Corpus ID: 19342361
Metastasis remains a main cause of death in patients with breast cancer regardless of improvements in treatment. Prospective…
Expand
2010
2010
Abstract 1136: Detection and characterization of circulating tumor cells in localized and metastatic prostate cancer patients using CTC-Chip microfluidic technology
S. Nagrath
,
Shannon L. Stott
,
+9 authors
M. Toner
2010
Corpus ID: 76626845
Despite recent molecular advances, the treatment of localized and metastatic prostate cancer has changed little in recent decades…
Expand
Review
2010
Review
2010
Circulating tumor cells in gastrointestinal cancer
H. Takeuchi
,
Y. Kitagawa
Journal of hepato-biliary-pancreatic sciences
2010
Corpus ID: 25511606
Since the first report in the nineteenth century, there have been numerous reports on the isolation and characterization of…
Expand
2007
2007
6-Year Experience of Concurrent Radiochemotherapy with Vinorelbine Plus a Platinum Compound in Multimorbid or Aged Patients with Inoperable Non-Small Cell Lung Cancer
S. Semrau
,
A. Bier
,
+4 authors
R. Fietkau
Strahlentherapie und Onkologie (Print)
2007
Corpus ID: 38099763
Background and Purpose:Although poor-risk patients represent no minority in inoperable non-small cell lung cancer (NSCLC), there…
Expand
2005
2005
Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease.
Bert T Chen
,
R. Loberg
,
+6 authors
Kenneth J. Pienta
Urology
2005
Corpus ID: 28122814
2003
2003
[Radiation therapy for Morbus Ledderhose -- indication and clinical results].
M. Seegenschmiedt
,
M. Attassi
Strahlentherapie und Onkologie (Print)
2003
Corpus ID: 116564033
BACKGROUND Morbus Ledderhose (ML) is a rare hyperproliferative disorder of the plantar aponeurosis which is similar in its…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required